August 15, 2024 Experience NatWest Group $1.75 billion senior notes offering We advised NatWest Group on the SEC-registered offering
August 6, 2024 Experience AC Immune $80 million at-the-market offering We advised AC Immune on the offering
August 2, 2024 Experience Banco Santander $1.5 billion Tier 1 capital securities offering We advised Banco Santander on its SEC-registered offering of contingent convertible securities
July 19, 2024 Experience Clariane €92 million reserved capital increase and €237 million rights offering We advised Clariane on its refinancing transactions
July 15, 2024 Experience Banco Santander $3.75 billion notes offering We advised Banco Santander on its offering of notes
July 2, 2024 Experience InflaRx $75 million at-the-market offering The shares are listed on the Nasdaq Global Market
July 1, 2024 Experience Millicom tender offer by Atlas Luxco We are advising Millicom’s independent committee on the tender offer
June 28, 2024 Experience Pepkor Holdings ZAR 9 billion secondary offering The accelerated bookbuild transaction represented approximately 13.6% of Pepkor’s issued share capital
June 12, 2024 Experience Harbour Energy $11.2 billion acquisition of Wintershall Dea upstream assets We are advising Barclays Bank as sponsor to Harbour Energy on the transaction
June 11, 2024 Experience Royalty Pharma $1.5 billion senior notes offering We advised Royalty Pharma on its investment-grade notes offering